2 1 The innovative transport systems and the CityMobil project 10 1.1 The research questions 10 2 The state of art in the field of automatic transport systems 12 2.1 Case studies and demand studies for innovative transport systems 12 3 The design and implementation of surveys 14 3.1 Definition of experimental design 14 3.2 Questionnaire design and delivery 16 3.3 First analyses on the collected sample 18 4 Calibration of Logit Multionomial demand models 21 4.1 Methodology 21 4.2 Calibration of the “full” model. 22 4.3 Calibration of the “final” model 24 4.4 The demand analysis through the final Multinomial Logit model 25 5 The analysis of interaction between the demand and socioeconomic attributes 31 5.1 Methodology 31 5.2 Application of Mixed Logit models to the demand 31 5.3 Analysis of the interactions between demand and socioeconomic attributes through Mixed Logit models 32 5.4 Mixed Logit model and interaction between age and the demand for the CTS 38 5.5 Demand analysis with Mixed Logit model 39 6 Final analyses and conclusions 45 6.1 Comparison between the results of the analyses 45 6.2 Conclusions 48 6.3 Answers to the research questions and future developments 52

The European commission

Social Network Analysis

Sustainable Development Goals

https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(12)62089-3.pdf

Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries

Merchants of Doubt. How a Handful of Scientists Obscured the Truth on Issues from Tobacco Smoke to Global Warming

This article aims to provide a review of music sponsorship to market cigarettes in sub-Saharan Africa. Using analysis of previously secret corporate documents from British American Tobacco (BAT) and focusing on two separate case studies of sponsorship in Africa, Nigeria and South Africa, the paper illustrates how tobacco companies have sought to undermine health legislation from 1990 to 2001. Both case studies suggest that music is an important marketing tool in Africa because it can effectively target young consumers; has a universal appeal; transcends barriers to communication imposed by limited literacy and language barriers; has a long-term appeal and can be successful in undermining tobacco control measures. The case studies highlight the limitations of national regulatory efforts and reinforce the significance of the implementation of the WHO's Framework Convention on Tobacco Control in Africa, a critical region for the convention's success.

Bringing 'Light, Life and Happiness': British American Tobacco and music sponsorship in sub-Saharan Africa

Corporate (anti)social (ir)responsibility: Transnational tobacco companies and the attempted subversion of global health policy

In May 2007, the Instituto Carso de la Salud—now Instituto Carlos Slim de la Salud (ICSS)—was endowed with US$500 million to focus on priority health issues in Latin America, notably issues of ‘globalisation and non-communicable diseases’ ICSS was soon criticised, however, on the grounds that its funding was derived from tobacco industry profits and that its founder Carlos Slim Helu remained an active industry principal Collaboration with ICSS was said to run counter to the WHO Framework Convention on Tobacco Control The Institute's then Executive President Julio Frenk disputed these charges This research employs an archive of tobacco industry documents triangulated with materials from commercial, media, regulatory and NGO sources to examine the financial relations between Slim and the tobacco industry The paper analyses Slim's continuing service to the industry and role in ICSS It demonstrates a prima facie conflict of interest between ICSS's health mission and its founder's involvement in cigarette manufacturing and marketing, reflected on ICSS's website as a resounding silence on issues of tobacco and health It is concluded that the reliance of international health agencies upon the commercial sector requires more robust institutional policies to effectively regulate conflicts of interest

https://tobaccocontrol.bmj.com/content/tobaccocontrol/19/6/e1.full.pdf

Uneasy money: the Instituto Carlos Slim de la Salud, tobacco philanthropy and conflict of interest in global health.

Background 
This paper examines the efforts of consultants affiliated with Philip Morris (PM), the world's leading transnational tobacco corporation, to influence scientific research and training in Thailand via the Chulabhorn Research Institute (CRI). A leading Southeast Asian institute for environmental health science, the CRI is headed by Professor Dr. Her Royal Highness Princess Chulabhorn, the daughter of the King of Thailand, and it has assumed international significance via its designation as a World Health Organization (WHO) Collaborating Centre in December 2005.
Methods and Findings 
This paper analyses previously confidential tobacco industry documents that were made publicly available following litigation in the United States. PM documents reveal that ostensibly independent overseas scientists, now identified as industry consultants, were able to gain access to the Thai scientific community. Most significantly, PM scientist Roger Walk has established close connections with the CRI. Documents indicate that Walk was able to use such links to influence the study and teaching of environmental toxicology in the institute and to develop relations with key officials and local scientists so as to advance the interests of PM within Thailand and across Asia. While sensitivities surrounding royal patronage of the CRI make public criticism extremely difficult, indications of ongoing involvement by tobacco industry consultants suggest the need for detailed scrutiny of such relationships.
Conclusions 
The establishment of close links with the CRI advances industry strategies to influence scientific research and debate around tobacco and health, particularly regarding secondhand smoke, to link with academic institutions, and to build relationships with national elites. Such strategies assume particular significance in the national and regional contexts presented here amid the globalisation of the tobacco pandemic. From an international perspective, particular concern is raised by the CRI's recently awarded status as a WHO Collaborating Centre. Since the network of WHO Collaborating Centres rests on the principle of “using national institutions for international purposes,” the documents presented below suggest that more rigorous safeguards are required to ensure that such use advances public health goals rather than the objectives of transnational corporations.

/pdf/a-good-personal-scientific-relationship-philip-morris-4lcnqoqlxp.pdf

''A Good Personal Scientific Relationship'': Philip Morris Scientists and the Chulabhorn Research Institute, Bangkok

Negotiators from the World Health Organization's 191 member states meet in Geneva this week in an attempt to agree the world's first international tobacco control treaty, the Framework Convention on Tobacco Control.1 This legally binding treaty would aim to establish principles and guidelines for international tobacco control. It follows a similar format to the 1992 United Nations' Framework Convention on Climate Change and its related protocols such as that signed in Kyoto in 1997. The development of a framework convention on tobacco is important because it is the first time in its history that the WHO has used its treaty making powers. And in the growing debate around trade and health it provides an opportunity to ensure that health is given primacy over commercial considerations when it comes to trade in a product that kills one in every two of its long term users.2

A global tobacco control treaty is now essential because the tobacco industry's use of international trade agreements, cigarette smuggling, 3 4 and global marketing techniques has undermined national …

https://www.bmj.com/content/bmj/325/7369/846.full.pdf

Jeff Collin

Papers

Bringing 'Light, Life and Happiness': British American Tobacco and music sponsorship in sub-Saharan Africa

Corporate (anti)social (ir)responsibility: Transnational tobacco companies and the attempted subversion of global health policy

Uneasy money: the Instituto Carlos Slim de la Salud, tobacco philanthropy and conflict of interest in global health.

''A Good Personal Scientific Relationship'': Philip Morris Scientists and the Chulabhorn Research Institute, Bangkok

The world's first international tobacco control treaty.